TOR1/YJR066W Literature Guide Help

Other names published for TOR1: DRR1, YJR066W

TOR1 - Strains/Constructs (131)

Results: 121 - 131 of 131 records
   1  2  3  4  5 
ReferenceOther Genes Addressed
Zheng XF and Schreiber SL  (1997) Target of rapamycin proteins and their kinase activities are required for meiosis. Proc Natl Acad Sci U S A 94(7):3070-5
Alarcon CM, et al.  (1996) Mammalian RAFT1 kinase domain provides rapamycin-sensitive TOR function in yeast. Genes Dev 10(3):279-88
Barbet NC, et al.  (1996) TOR controls translation initiation and early G1 progression in yeast. Mol Biol Cell 7(1):25-42
Freeman K and Livi GP  (1996) Missense mutations at the FKBP12-rapamycin-binding site of TOR1. Gene 172(1):143-7
Lorenz MC and Heitman J  (1995) TOR mutations confer rapamycin resistance by preventing interaction with FKBP12-rapamycin. J Biol Chem 270(46):27531-7
Zheng XF, et al.  (1995) TOR kinase domains are required for two distinct functions, only one of which is inhibited by rapamycin. Cell 82(1):121-30
Cafferkey R, et al.  (1994) Yeast TOR (DRR) proteins: amino-acid sequence alignment and identification of structural motifs. Gene 141(1):133-6
Helliwell SB, et al.  (1994) TOR1 and TOR2 are structurally and functionally similar but not identical phosphatidylinositol kinase homologues in yeast. Mol Biol Cell 5(1):105-18
Stan R, et al.  (1994) Interaction between FKBP12-rapamycin and TOR involves a conserved serine residue. J Biol Chem 269(51):32027-30
Cafferkey R, et al.  (1993) Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity. Mol Cell Biol 13(10):6012-23
Heitman J, et al.  (1991) Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253(5022):905-9
Results: 121 - 131 of 131 records
   1  2  3  4  5